Effect of recombinant bovine somatotropin on superovulatory response and recipient pregnancy rates in a commercial embryo transfer program

Recombinant bovine somatotropin (rbST) has been shown to increase follicular growth in cattle and some studies have demonstrated an increase in superovulatory response for rbST-treated cows. Pregnancy rates have also been shown to increase when rbST was administered around the time of insemination o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Theriogenology 2003-05, Vol.59 (9), p.1919-1928
Hauptverfasser: Hasler, J.F, Bilby, C.R, Collier, R.J, Denham, S.C, Lucy, M.C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1928
container_issue 9
container_start_page 1919
container_title Theriogenology
container_volume 59
creator Hasler, J.F
Bilby, C.R
Collier, R.J
Denham, S.C
Lucy, M.C
description Recombinant bovine somatotropin (rbST) has been shown to increase follicular growth in cattle and some studies have demonstrated an increase in superovulatory response for rbST-treated cows. Pregnancy rates have also been shown to increase when rbST was administered around the time of insemination or prior to embryo transfer. The application of rbST for the purpose of increasing superovulatory responses of donor cows and increasing pregnancy rates of recipient heifers was tested in a commercial embryo transfer program. In Experiment 1, embryo donor cows ( n=56) underwent three cycles of control superovulation (two before and one after weaning) and subsequently underwent up to four additional superovulations while being treated with either rbST (500 mg sustained-release rbST; Posilac, Monsanto, St. Louis, MO; n=28) or excipient (control; n=28) once every 14 days. In Experiment 2, lactating embryo donor cows ( n=37) underwent a control superovulation and then underwent a superovulation while lactating and being treated with either rbST ( n=16) or excipient ( n=21). In Experiment 3, embryo recipient heifers that were being implanted with either in vitro or in vivo produced embryos were treated with either rbST ( n=146) or excipient ( n=143) at the time of embryo transfer. Treatment of non-lactating (Experiment 1) or lactating (Experiment 2) donor cows with rbST during repeated superovulation did not affect the number of corpora lutea, the sum of transferable embryos, degenerate embryos, and unfertilized oocytes, or the number of transferable embryos. Treatment of recipient heifers with rbST (Experiment 3) did not affect pregnancy rates for either in vitro or in vivo produced embryos. We conclude that superovulatory response and pregnancy rates (respectively) are similar to control for rbST-treated cows undergoing repeated superovulations and rbST-treated recipient heifers treated at the time of embryo transfer.
doi_str_mv 10.1016/S0093-691X(02)01295-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73045187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0093691X02012955</els_id><sourcerecordid>73045187</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-b109eef8b091ac0ecbbe9a1e1171a4d8d5e0c4bf11e4fd737f28b9bd0180fa203</originalsourceid><addsrcrecordid>eNqFkc2KFDEUhYMoTs_oIyhZiS5K763_rESGcRQGXKjgLiSpmyFSlZRJqqFfwac2Pd3o0lXg8p1zyDmMvUB4i4D9u68Aoql6gT9eQ_0GsBZd1T1iOxwHUTV1g4_Z7i9ywS5T-gkATd_jU3aBdQ8w1GLHft9YSybzYHkkExbtvPKZ67B3nngKi8ohx7A6z4PnaVsphv02l2s8FEVag0_ElZ-Ocrc6KuI10n1xMQVQmRIvWsWL90LRODVzWnQ8BJ6j8slSLHy4j2p5xp5YNSd6fn6v2PePN9-uP1V3X24_X3-4q0yLTa40giCyowaBygAZrUkoJMQBVTuNU0dgWm0RqbXT0Ay2HrXQE-AIVtXQXLFXJ9-S-2ujlOXikqF5Vp7CluTQQNuVGgvYnUATQ0qRrFyjW1Q8SAR5HEE-jCCPDUuo5cMIsiu6l-eATS80_VOdWy_A-xNA5Zt7R1EmU5ozNLnSYpZTcP-J-ANnoZwr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73045187</pqid></control><display><type>article</type><title>Effect of recombinant bovine somatotropin on superovulatory response and recipient pregnancy rates in a commercial embryo transfer program</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Hasler, J.F ; Bilby, C.R ; Collier, R.J ; Denham, S.C ; Lucy, M.C</creator><creatorcontrib>Hasler, J.F ; Bilby, C.R ; Collier, R.J ; Denham, S.C ; Lucy, M.C</creatorcontrib><description>Recombinant bovine somatotropin (rbST) has been shown to increase follicular growth in cattle and some studies have demonstrated an increase in superovulatory response for rbST-treated cows. Pregnancy rates have also been shown to increase when rbST was administered around the time of insemination or prior to embryo transfer. The application of rbST for the purpose of increasing superovulatory responses of donor cows and increasing pregnancy rates of recipient heifers was tested in a commercial embryo transfer program. In Experiment 1, embryo donor cows ( n=56) underwent three cycles of control superovulation (two before and one after weaning) and subsequently underwent up to four additional superovulations while being treated with either rbST (500 mg sustained-release rbST; Posilac, Monsanto, St. Louis, MO; n=28) or excipient (control; n=28) once every 14 days. In Experiment 2, lactating embryo donor cows ( n=37) underwent a control superovulation and then underwent a superovulation while lactating and being treated with either rbST ( n=16) or excipient ( n=21). In Experiment 3, embryo recipient heifers that were being implanted with either in vitro or in vivo produced embryos were treated with either rbST ( n=146) or excipient ( n=143) at the time of embryo transfer. Treatment of non-lactating (Experiment 1) or lactating (Experiment 2) donor cows with rbST during repeated superovulation did not affect the number of corpora lutea, the sum of transferable embryos, degenerate embryos, and unfertilized oocytes, or the number of transferable embryos. Treatment of recipient heifers with rbST (Experiment 3) did not affect pregnancy rates for either in vitro or in vivo produced embryos. We conclude that superovulatory response and pregnancy rates (respectively) are similar to control for rbST-treated cows undergoing repeated superovulations and rbST-treated recipient heifers treated at the time of embryo transfer.</description><identifier>ISSN: 0093-691X</identifier><identifier>EISSN: 1879-3231</identifier><identifier>DOI: 10.1016/S0093-691X(02)01295-5</identifier><identifier>PMID: 12600729</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Cattle - physiology ; Corpus Luteum - anatomy &amp; histology ; Donor ; Embryo ; Embryo Transfer - veterinary ; Female ; Growth Hormone - pharmacology ; Lactation ; Oocyte Donation - veterinary ; Pregnancy ; rbST ; Recipient ; Superovulation</subject><ispartof>Theriogenology, 2003-05, Vol.59 (9), p.1919-1928</ispartof><rights>2002 Elsevier Science Inc.</rights><rights>Copyright 2002 Elsevier Science Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-b109eef8b091ac0ecbbe9a1e1171a4d8d5e0c4bf11e4fd737f28b9bd0180fa203</citedby><cites>FETCH-LOGICAL-c413t-b109eef8b091ac0ecbbe9a1e1171a4d8d5e0c4bf11e4fd737f28b9bd0180fa203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0093691X02012955$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12600729$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hasler, J.F</creatorcontrib><creatorcontrib>Bilby, C.R</creatorcontrib><creatorcontrib>Collier, R.J</creatorcontrib><creatorcontrib>Denham, S.C</creatorcontrib><creatorcontrib>Lucy, M.C</creatorcontrib><title>Effect of recombinant bovine somatotropin on superovulatory response and recipient pregnancy rates in a commercial embryo transfer program</title><title>Theriogenology</title><addtitle>Theriogenology</addtitle><description>Recombinant bovine somatotropin (rbST) has been shown to increase follicular growth in cattle and some studies have demonstrated an increase in superovulatory response for rbST-treated cows. Pregnancy rates have also been shown to increase when rbST was administered around the time of insemination or prior to embryo transfer. The application of rbST for the purpose of increasing superovulatory responses of donor cows and increasing pregnancy rates of recipient heifers was tested in a commercial embryo transfer program. In Experiment 1, embryo donor cows ( n=56) underwent three cycles of control superovulation (two before and one after weaning) and subsequently underwent up to four additional superovulations while being treated with either rbST (500 mg sustained-release rbST; Posilac, Monsanto, St. Louis, MO; n=28) or excipient (control; n=28) once every 14 days. In Experiment 2, lactating embryo donor cows ( n=37) underwent a control superovulation and then underwent a superovulation while lactating and being treated with either rbST ( n=16) or excipient ( n=21). In Experiment 3, embryo recipient heifers that were being implanted with either in vitro or in vivo produced embryos were treated with either rbST ( n=146) or excipient ( n=143) at the time of embryo transfer. Treatment of non-lactating (Experiment 1) or lactating (Experiment 2) donor cows with rbST during repeated superovulation did not affect the number of corpora lutea, the sum of transferable embryos, degenerate embryos, and unfertilized oocytes, or the number of transferable embryos. Treatment of recipient heifers with rbST (Experiment 3) did not affect pregnancy rates for either in vitro or in vivo produced embryos. We conclude that superovulatory response and pregnancy rates (respectively) are similar to control for rbST-treated cows undergoing repeated superovulations and rbST-treated recipient heifers treated at the time of embryo transfer.</description><subject>Animals</subject><subject>Cattle - physiology</subject><subject>Corpus Luteum - anatomy &amp; histology</subject><subject>Donor</subject><subject>Embryo</subject><subject>Embryo Transfer - veterinary</subject><subject>Female</subject><subject>Growth Hormone - pharmacology</subject><subject>Lactation</subject><subject>Oocyte Donation - veterinary</subject><subject>Pregnancy</subject><subject>rbST</subject><subject>Recipient</subject><subject>Superovulation</subject><issn>0093-691X</issn><issn>1879-3231</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc2KFDEUhYMoTs_oIyhZiS5K763_rESGcRQGXKjgLiSpmyFSlZRJqqFfwac2Pd3o0lXg8p1zyDmMvUB4i4D9u68Aoql6gT9eQ_0GsBZd1T1iOxwHUTV1g4_Z7i9ywS5T-gkATd_jU3aBdQ8w1GLHft9YSybzYHkkExbtvPKZ67B3nngKi8ohx7A6z4PnaVsphv02l2s8FEVag0_ElZ-Ocrc6KuI10n1xMQVQmRIvWsWL90LRODVzWnQ8BJ6j8slSLHy4j2p5xp5YNSd6fn6v2PePN9-uP1V3X24_X3-4q0yLTa40giCyowaBygAZrUkoJMQBVTuNU0dgWm0RqbXT0Ay2HrXQE-AIVtXQXLFXJ9-S-2ujlOXikqF5Vp7CluTQQNuVGgvYnUATQ0qRrFyjW1Q8SAR5HEE-jCCPDUuo5cMIsiu6l-eATS80_VOdWy_A-xNA5Zt7R1EmU5ozNLnSYpZTcP-J-ANnoZwr</recordid><startdate>20030501</startdate><enddate>20030501</enddate><creator>Hasler, J.F</creator><creator>Bilby, C.R</creator><creator>Collier, R.J</creator><creator>Denham, S.C</creator><creator>Lucy, M.C</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030501</creationdate><title>Effect of recombinant bovine somatotropin on superovulatory response and recipient pregnancy rates in a commercial embryo transfer program</title><author>Hasler, J.F ; Bilby, C.R ; Collier, R.J ; Denham, S.C ; Lucy, M.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-b109eef8b091ac0ecbbe9a1e1171a4d8d5e0c4bf11e4fd737f28b9bd0180fa203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Cattle - physiology</topic><topic>Corpus Luteum - anatomy &amp; histology</topic><topic>Donor</topic><topic>Embryo</topic><topic>Embryo Transfer - veterinary</topic><topic>Female</topic><topic>Growth Hormone - pharmacology</topic><topic>Lactation</topic><topic>Oocyte Donation - veterinary</topic><topic>Pregnancy</topic><topic>rbST</topic><topic>Recipient</topic><topic>Superovulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hasler, J.F</creatorcontrib><creatorcontrib>Bilby, C.R</creatorcontrib><creatorcontrib>Collier, R.J</creatorcontrib><creatorcontrib>Denham, S.C</creatorcontrib><creatorcontrib>Lucy, M.C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Theriogenology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hasler, J.F</au><au>Bilby, C.R</au><au>Collier, R.J</au><au>Denham, S.C</au><au>Lucy, M.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of recombinant bovine somatotropin on superovulatory response and recipient pregnancy rates in a commercial embryo transfer program</atitle><jtitle>Theriogenology</jtitle><addtitle>Theriogenology</addtitle><date>2003-05-01</date><risdate>2003</risdate><volume>59</volume><issue>9</issue><spage>1919</spage><epage>1928</epage><pages>1919-1928</pages><issn>0093-691X</issn><eissn>1879-3231</eissn><abstract>Recombinant bovine somatotropin (rbST) has been shown to increase follicular growth in cattle and some studies have demonstrated an increase in superovulatory response for rbST-treated cows. Pregnancy rates have also been shown to increase when rbST was administered around the time of insemination or prior to embryo transfer. The application of rbST for the purpose of increasing superovulatory responses of donor cows and increasing pregnancy rates of recipient heifers was tested in a commercial embryo transfer program. In Experiment 1, embryo donor cows ( n=56) underwent three cycles of control superovulation (two before and one after weaning) and subsequently underwent up to four additional superovulations while being treated with either rbST (500 mg sustained-release rbST; Posilac, Monsanto, St. Louis, MO; n=28) or excipient (control; n=28) once every 14 days. In Experiment 2, lactating embryo donor cows ( n=37) underwent a control superovulation and then underwent a superovulation while lactating and being treated with either rbST ( n=16) or excipient ( n=21). In Experiment 3, embryo recipient heifers that were being implanted with either in vitro or in vivo produced embryos were treated with either rbST ( n=146) or excipient ( n=143) at the time of embryo transfer. Treatment of non-lactating (Experiment 1) or lactating (Experiment 2) donor cows with rbST during repeated superovulation did not affect the number of corpora lutea, the sum of transferable embryos, degenerate embryos, and unfertilized oocytes, or the number of transferable embryos. Treatment of recipient heifers with rbST (Experiment 3) did not affect pregnancy rates for either in vitro or in vivo produced embryos. We conclude that superovulatory response and pregnancy rates (respectively) are similar to control for rbST-treated cows undergoing repeated superovulations and rbST-treated recipient heifers treated at the time of embryo transfer.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>12600729</pmid><doi>10.1016/S0093-691X(02)01295-5</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0093-691X
ispartof Theriogenology, 2003-05, Vol.59 (9), p.1919-1928
issn 0093-691X
1879-3231
language eng
recordid cdi_proquest_miscellaneous_73045187
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Cattle - physiology
Corpus Luteum - anatomy & histology
Donor
Embryo
Embryo Transfer - veterinary
Female
Growth Hormone - pharmacology
Lactation
Oocyte Donation - veterinary
Pregnancy
rbST
Recipient
Superovulation
title Effect of recombinant bovine somatotropin on superovulatory response and recipient pregnancy rates in a commercial embryo transfer program
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T22%3A14%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20recombinant%20bovine%20somatotropin%20on%20superovulatory%20response%20and%20recipient%20pregnancy%20rates%20in%20a%20commercial%20embryo%20transfer%20program&rft.jtitle=Theriogenology&rft.au=Hasler,%20J.F&rft.date=2003-05-01&rft.volume=59&rft.issue=9&rft.spage=1919&rft.epage=1928&rft.pages=1919-1928&rft.issn=0093-691X&rft.eissn=1879-3231&rft_id=info:doi/10.1016/S0093-691X(02)01295-5&rft_dat=%3Cproquest_cross%3E73045187%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73045187&rft_id=info:pmid/12600729&rft_els_id=S0093691X02012955&rfr_iscdi=true